| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Building smart CAR T cell therapies: The path to overcome current challenges
|
Cai, Qi
|
|
|
41 |
10 |
p. 1689-1695
|
article
|
| 2 |
CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1
|
Miao, Beiping
|
|
|
41 |
10 |
p. 1817-1828.e9
|
article
|
| 3 |
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
|
Pan, Yi
|
|
|
41 |
10 |
p. 1763-1773.e4
|
article
|
| 4 |
Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance
|
Gjuka, Donjeta
|
|
|
41 |
10 |
p. 1774-1787.e9
|
article
|
| 5 |
Genetically informed therapy for lymphoma: the discomfiting benefit of lumping splits
|
Hahn, Cynthia K.
|
|
|
41 |
10 |
p. 1696-1698
|
article
|
| 6 |
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial
|
Zhang, Mu-Chen
|
|
|
41 |
10 |
p. 1705-1716.e5
|
article
|
| 7 |
Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer
|
Chen, Kezhong
|
|
|
41 |
10 |
p. 1749-1762.e6
|
article
|
| 8 |
Integrating minimal residual disease monitoring into clinical practice for NSCLC: Is the era upon us?
|
Li, Ziming
|
|
|
41 |
10 |
p. 1699-1701
|
article
|
| 9 |
Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden
|
Zhu, Mingrui
|
|
|
41 |
10 |
p. 1731-1748.e8
|
article
|
| 10 |
PD-L1 and CD58 co-regulated by CMTM6 play yin and yang to shape anti-tumor immunity
|
Yamaguchi, Hirohito
|
|
|
41 |
10 |
p. 1701-1704
|
article
|
| 11 |
Sensitizing cancer cells to immune checkpoint inhibitors by microbiota-mediated upregulation of HLA class I
|
Ferrari, Valentina
|
|
|
41 |
10 |
p. 1717-1730.e4
|
article
|
| 12 |
Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution
|
Zhang, Hongyi
|
|
|
41 |
10 |
p. 1788-1802.e10
|
article
|
| 13 |
ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome
|
Parry, Erin M.
|
|
|
41 |
10 |
p. 1803-1816.e8
|
article
|
Journal description